adjuv
enhanc
mucos
immun
respons
prefer
control
mani
pathogen
portal
entri
earlier
report
tolllikereceptor
agonist
resiquimod
stimul
system
immun
adjuv
inactiv
newcastl
diseas
viru
vaccin
chicken
report
effect
adjuv
live
inactiv
avian
infecti
bronchiti
viru
ibv
vaccin
special
emphasi
mucos
immun
specif
pathogen
free
spf
chick
n
equal
divid
six
group
two
week
age
immun
either
inactiv
live
ibv
vaccin
adjuv
without
group
receiv
either
pb
serv
control
booster
given
day
postimmun
dpi
enhanc
antigen
specif
humor
cellular
immun
respons
coadminist
vaccin
evidenc
increas
antibodi
titr
elisa
stimul
index
lymphocyt
transform
test
ltt
till
dpi
increas
proport
cell
dpi
flow
cytometri
interestingli
potenti
iga
respons
tear
intestin
secret
use
live
inactiv
ibv
vaccin
combin
ibv
vaccin
significantli
upregul
transform
growth
factor
beta
transcript
peripher
blood
mononuclear
cell
pbmc
respect
vaccin
per
se
enhanc
secretori
iga
respons
like
due
upregul
respons
class
switch
iga
conclus
coadministr
inactiv
live
ibv
vaccin
enhanc
system
well
mucos
immun
respons
chicken
avian
infecti
bronchiti
ib
acut
highli
contagi
diseas
age
group
chicken
affect
primarili
respiratori
system
possibl
infect
renal
reproduct
system
diseas
global
import
list
world
organ
anim
health
oie
diseas
infecti
bronchiti
viru
ibv
caus
agent
ib
belong
genu
coronaviru
famili
coronovirida
order
nidoviral
vaccin
live
attenu
inactiv
vaccin
mainstay
tool
control
ib
ibv
enter
host
mucos
surfac
replic
epitheli
cell
vaccin
induc
mucos
immun
prevent
entri
pathogen
establish
infect
studi
indic
local
administr
attenu
ibv
vaccin
effect
compar
system
administr
impli
respiratori
mucos
immun
essenti
protect
fact
increas
lachrymalfluid
iga
level
chicken
increas
resist
ibv
infect
reinfect
inbr
chicken
line
resist
ibv
correl
higher
iga
level
tear
saliva
limit
number
adjuv
avail
capac
enhanc
antigen
specif
mucos
immun
convent
mucos
adjuv
like
heatlabil
enterotoxin
lt
e
coli
cholera
toxin
ct
vibrio
cholera
toxic
host
owe
immunostimulatori
capac
tolllik
receptor
tlr
agonist
explor
altern
promis
sourc
futur
adjuv
system
emerg
evid
support
notion
tlr
agonist
increas
secretori
iga
siga
use
vaccin
antigen
lp
agonist
use
inactiv
newcastl
diseas
viru
ndv
vaccin
significantli
increas
mucos
humor
immun
respons
flagellin
combin
cpg
poli
c
increas
siga
titr
along
system
immun
respons
chicken
avian
influenza
viru
vaccin
resiquimod
agonist
gardiquimod
agonist
enhanc
siga
respons
besid
cellular
humor
respons
use
viru
like
particl
vlp
base
norwalk
viru
vaccin
mice
respons
seen
equival
seen
cholera
toxin
use
adjuv
antigen
codeliveri
norwalk
vlp
gardiquimod
agonist
cpg
odn
agonist
produc
strong
system
well
mucos
immun
respons
mice
recent
report
adjuv
potenti
chicken
use
inactiv
ndv
vaccin
howev
effect
mucos
immun
respons
explor
chicken
hitherto
accordingli
investig
system
well
mucos
immun
respons
live
inactiv
ibv
vaccin
chicken
adjuv
specif
pathogen
free
spf
embryon
egg
procur
venki
india
privat
limit
pune
india
hatch
central
avian
research
institut
izatnagar
bird
maintain
follow
standard
manag
practic
provid
ad
libitum
steril
feed
water
experi
approv
institut
anim
ethic
committe
agonist
resiquimod
sourc
invivogen
california
usa
live
inactiv
massachusett
strain
ibv
vaccin
purchas
commerci
sourc
two
week
old
spf
chick
immun
live
inactiv
ibv
vaccin
presenc
absenc
tabl
booster
given
day
postimmun
dpi
ibv
specif
antibodi
level
evalu
serum
weekli
interv
level
siga
check
tear
intestin
secret
experiment
bird
weekli
interv
booster
dose
cellular
immun
respons
evalu
lymphocyt
transform
test
ltt
dpi
flow
cytometri
dpi
express
tgf
transcript
peripher
blood
mononuclear
cell
pbmc
experiment
bird
quantifi
h
postboost
dose
quantit
real
time
polymeras
chain
reaction
qpcr
qpcr
analysi
tgf
transcript
also
done
spleen
sampl
dpi
bird
two
week
age
randomli
divid
six
group
n
immun
withliv
kill
ibv
vaccin
tabl
booster
given
dose
rout
dpi
given
intramuscular
rout
im
blood
sampl
n
dpi
n
dpi
collect
separ
sera
store
detect
ibv
specif
antibodi
level
dpi
tear
sampl
n
dpi
n
dpi
collect
experiment
bird
report
elsewher
dpi
briefli
pinch
molecular
grade
sodium
chlorid
crystal
sprinkl
either
eye
induc
lachrym
within
tear
aspir
micropipett
store
microcentrifug
tube
iga
assay
bird
n
human
sacrif
dpi
spleen
intestin
secret
collect
report
earlier
briefli
around
cm
long
duodenum
jejunum
ileum
collect
bird
pool
pariet
surfac
wash
pb
longitudin
strip
intestin
prepar
place
graduat
tube
equal
volum
pb
vv
contain
ethylen
diamin
tetraacet
edta
mm
trypsin
inhibitor
phenyl
methan
sulfonyl
fluorid
pmsf
mgml
ad
sampl
vortex
briefli
min
centrifug
g
min
clear
supernat
aspir
kept
use
pbmc
isol
experiment
bird
n
group
h
postboost
dose
use
ficol
hypaqu
sigma
mo
usa
gml
densiti
gradient
centrifug
per
publish
protocol
ibv
specif
antibodi
serum
n
dpi
n
dpi
quantifi
use
commerci
ibv
antibodi
test
kit
idexx
laboratori
usa
follow
manufactur
instruct
antibodi
titr
log
consid
posit
ibv
level
iga
tear
n
dpi
n
dpi
intestin
secret
n
measur
use
commerci
ibv
antibodi
test
kit
idexx
laboratori
usa
certain
modif
use
antichicken
igahrpo
bethyl
usa
secondari
antibodi
cellular
immun
respons
experiment
bird
assess
lymphocyt
transform
test
ltt
flow
cytometri
report
earlier
blood
collect
heparin
vial
contain
iuml
dpi
ltt
pbmc
n
dpi
n
dpi
suspend
rpmi
complet
medium
contain
fetal
bovin
serum
fb
iuml
penicillin
streptomycin
cell
viabil
determin
trypan
blue
dye
exclus
method
cell
suspens
adjust
cellsml
cell
suspens
plate
well
well
cell
cultur
plate
rpmi
medium
without
cona
ibv
antigen
ad
well
triplic
plate
incub
co
h
humidifi
chamber
end
incub
mtt
bromid
sigma
usa
ad
stock
mgml
plate
reincub
condit
anoth
h
cultur
supernat
tabl
immun
plan
follow
spf
chicken
vaccin
prepar
rout
discard
well
formazan
crystal
dissolv
ad
dimethyl
sulfoxid
amresco
usa
well
optic
densiti
od
taken
nm
micropl
elisa
reader
blastogen
respons
calcul
divid
mean
od
stimul
well
mean
od
unstimul
well
express
stimul
index
si
flow
cytometri
analysi
proport
cell
subset
pbmc
n
measur
dpi
flow
cytometri
analysi
cell
stain
antichicken
rpe
label
monoclon
antibodi
abcam
usa
kept
overnight
dark
subsequ
cell
wash
pb
contain
fb
fix
aliquot
cell
analyz
per
sampl
bd
fac
tm
calibur
instrument
bd
bioscienc
uk
unstain
cell
serv
neg
control
pbmc
n
collect
experiment
bird
mention
h
postboost
one
ml
amresco
usa
ad
similarli
one
ml
ad
spleen
tissu
collect
follow
sacrific
n
total
rna
extract
done
phenol
chloroform
isopropanol
method
puriti
check
absorb
nm
nanodrop
uv
spectrophotomet
total
rna
use
prepar
cdna
employ
first
strand
cdna
synthesi
kit
thermo
scientif
usa
follow
manufactur
instruct
quantif
gene
done
quantitect
sybr
green
qpcr
kit
qiagen
ca
usa
real
time
system
biorad
ca
usa
follow
publish
report
serv
housekeep
gene
publish
primer
sequenc
use
f
tatgtgcaaggccggttt
r
tgtctttctggcccat
accaa
f
cggccgacgatgagtggctc
r
cggggcccatctcacaggga
gene
sampl
test
triplic
plate
express
calcul
rel
gene
express
nfold
increas
decreas
rel
control
data
real
time
pcr
calcul
method
experi
repeat
twice
independ
data
first
experi
use
analysi
treatment
effect
time
point
assess
one
way
analysi
varianc
anova
duncan
multipl
rang
test
post
hoc
test
find
signific
pairwis
mean
differ
minimum
level
signific
set
result
present
mean
se
statist
softwar
ibm
corp
usa
use
analysi
graphpad
prism
version
use
gener
graph
effect
vaccin
induc
ibv
antibodi
titr
sera
present
fig
antibodi
titr
pb
control
group
consist
neg
ibv
signific
p
differ
antibodi
respons
vaccin
control
group
dpi
live
ibv
vaccin
without
induc
significantli
higher
antibodi
respons
control
group
dpi
combin
vaccin
plu
show
significantli
higher
p
antibodi
titr
respect
vaccin
alon
group
secondari
immun
consist
fig
effect
vaccin
induc
iga
respons
tear
intestin
secret
present
fig
respect
vaccin
either
live
inactiv
induc
significantli
higher
iga
respons
control
group
secondari
vaccin
p
coadministr
live
inactiv
ibv
vaccin
significantli
increas
iga
respons
tear
intestin
secret
dpi
maintain
till
dpi
compar
vaccin
alon
group
p
peak
iga
respons
tear
observ
live
vaccin
plu
group
follow
inactiv
vaccin
plu
live
vaccin
inactiv
vaccin
group
iga
respons
intestin
secret
compar
tear
antigen
specif
lymphocyt
prolifer
follow
differ
treatment
depict
fig
live
well
inactiv
ibv
vaccin
significantli
increas
si
compar
control
time
point
studi
coadministr
significantli
potenti
si
compar
vaccin
alon
group
p
si
maximum
live
vaccin
plu
group
dpi
respect
fig
live
inactiv
vaccin
significantli
increas
cell
compar
control
p
depict
fig
coadministr
either
type
vaccin
show
signific
increas
cell
indic
immunomodulatori
role
adapt
immun
combin
live
vaccin
show
highest
percent
increas
respect
cell
group
receiv
vaccin
along
show
significantli
p
higher
express
respect
vaccin
alon
group
fig
highest
transcript
observ
live
vaccin
plu
group
fold
higher
control
group
h
postboost
immun
respect
respons
seen
inactiv
vaccin
plu
group
almost
equal
live
vaccin
alon
group
express
transcript
compar
spleen
data
shown
pbmc
resiquimod
agonist
imidazoquinolin
compound
tremend
immunodulatori
capac
antivir
activ
agonist
report
genit
wart
herp
genitalia
molluscum
contagiosum
tlr
agonist
like
imiquimod
fda
approv
drug
basal
cell
carcinoma
actin
keratosi
papilloma
viru
human
recent
report
enhanc
antigen
specif
cellular
well
humor
immun
respons
chicken
resiquimod
use
inactiv
ndv
vaccin
result
complet
protect
virul
ndv
challeng
sinc
adjuv
potenti
like
vari
type
vaccin
studi
effect
ibv
vaccin
best
knowledg
first
report
effect
modul
mucos
immun
respons
chicken
humor
immun
respons
play
import
role
ibv
infect
present
studi
antibodi
titr
highest
spf
chicken
receiv
live
vaccin
group
fig
live
vaccin
viru
stimul
vigor
immun
respons
replic
host
simul
natur
infect
adjuv
live
ibv
vaccin
induc
higher
immun
respons
live
vaccin
alon
support
concept
present
studi
combin
withinactiv
ibv
vaccin
show
higher
antibodi
respons
vaccin
alon
group
find
indic
adjuv
capac
live
well
inactiv
ibv
vaccin
increas
antibodi
respons
support
earlier
report
inactiv
ndv
vaccin
spf
chicken
addit
antibodi
cell
mediat
immun
also
play
import
role
immun
ibv
transfer
lymphocyt
bird
day
postibv
infect
chicken
complet
elimin
viral
infect
clinic
sign
challeng
viral
load
reduc
lung
increas
ibvspecif
cytotox
cell
ctl
spleen
present
studi
cell
mediat
immun
analyz
ltt
well
immunophenotyp
found
spf
chicken
receiv
live
vaccin
mount
strong
antigen
specif
prolifer
compar
group
fig
support
concomit
increas
proport
cell
fig
similarli
enhanc
cellular
immun
respons
inactiv
ibv
vaccin
record
present
studi
support
find
inactiv
ndv
vaccin
need
adjuv
increas
antigen
specif
mucos
immun
respons
curtail
infect
entri
level
despit
fact
local
ctl
essenti
viru
clearanc
earli
infect
siga
lacrim
origin
good
indic
protect
ibv
infect
mucos
antibodi
respons
resist
reinfect
enhanc
siga
respons
tear
fig
well
intestin
secret
fig
adjuv
live
fig
vaccin
induc
ibv
antibodi
titr
spf
chicken
presenc
absenc
bird
week
age
immun
live
inactiv
ibv
vaccin
presenc
absenc
booster
day
later
antibodi
respons
monitor
serum
sampl
commerci
elisa
kit
idexx
laboratori
usa
weekli
interv
till
dpi
n
group
dpi
n
dpi
experi
repeat
twice
independ
data
first
experi
use
analysi
treatment
effect
analyz
time
point
one
way
anova
duncan
multipl
rang
test
compar
pairwis
mean
differ
alpha
error
set
indic
signific
differ
p
group
ibv
specif
antibodi
titr
log
consid
posit
dpi
day
postimmun
fig
vaccin
induc
ibv
specif
iga
concentr
tear
spf
chicken
presenc
absenc
bird
week
age
immun
live
inactiv
ibv
vaccin
presenc
absenc
booster
day
later
iga
respons
monitor
booster
weekli
interv
till
dpi
n
group
dpi
n
dpi
experi
repeat
twice
independ
data
first
experi
use
analysi
treatment
effect
analyz
time
point
one
way
anova
duncan
multipl
rang
test
compar
pairwis
mean
differ
alpha
error
set
indic
signific
differ
p
group
dpi
day
postimmun
fig
vaccin
induc
ibv
specif
iga
level
intestin
secret
spf
chicken
presenc
absenc
bird
week
age
immun
live
inactiv
ibv
vaccin
presenc
absenc
one
dose
prepar
day
later
iga
respons
monitor
booster
dose
weekli
interv
till
dpi
n
experi
repeat
twice
independ
data
first
experi
use
analysi
treatment
effect
analyz
time
point
one
way
anova
duncan
multipl
rang
test
compar
pairwis
mean
differ
alpha
error
set
indic
signific
differ
p
group
dpi
day
postimmun
inactiv
ibv
vaccin
support
find
report
administr
vlp
norwalk
viru
enhanc
mucos
iga
respons
mice
explain
impress
siga
respons
studi
rel
express
major
role
induct
iga
class
switch
well
known
orthologu
primarili
respons
class
switch
b
cell
produc
iga
mammal
signific
increas
rel
copi
number
fig
suggest
role
iga
class
switch
group
receiv
live
inactiv
ibv
vaccin
studi
transcript
significantli
higher
vaccin
plu
group
respect
vaccin
alon
group
activ
would
initi
signal
cascad
pathway
might
result
upregul
transcript
studi
group
shown
improv
vaccin
respons
ndv
adjuv
prophylact
potenti
ibdv
thu
adjuv
effect
ibv
need
test
follow
challeng
studi
conclus
coadministr
inactiv
live
ibv
vaccin
enhanc
mucos
immun
increas
siga
like
mediat
potenti
enhanc
mucos
immun
translat
signific
poultri
vaccin
fig
lymphocyt
prolifer
specif
ibv
antigen
pbmc
collect
spf
chicken
follow
vaccin
presenc
absenc
bird
week
age
immun
live
inactiv
ibv
vaccin
presenc
absenc
booster
day
later
pbmc
n
dpi
n
dpi
collect
stimul
ibv
antigen
assess
lymphocyt
prolifer
use
mtt
dye
weekli
interv
dpi
experi
repeat
twice
independ
data
first
experi
use
analysi
treatment
effect
analyz
time
point
one
way
anova
duncan
multipl
rang
test
compar
pairwis
mean
differ
alpha
error
set
indic
signific
differ
p
group
dpi
day
postimmun
cell
pbmc
spf
chicken
follow
ibv
vaccin
presenc
absenc
bird
week
age
immun
live
inactiv
ibv
vaccin
presenc
absenc
booster
day
later
pbmc
n
collect
bird
dpi
analyz
flow
cytometri
follow
addit
chicken
specif
monoclon
antibodi
experi
repeat
twice
independ
data
first
experi
use
analysi
treatment
effect
analyz
one
way
anova
duncan
multipl
rang
test
compar
pairwis
mean
differ
alpha
error
set
indic
signific
differ
p
group
dpi
day
postimmun
fig
quantit
real
time
pcr
analysi
express
pbmc
spf
chicken
follow
vaccin
presenc
absenc
bird
week
age
immun
live
inactiv
ibv
vaccin
presenc
absenc
booster
day
later
pbmc
n
collect
bird
dpi
h
postboost
transcript
analyz
real
time
pcr
use
hous
keep
gene
express
nfold
increas
decreas
rel
control
follow
method
experi
repeat
twice
independ
data
first
experi
use
analysi
treatment
effect
analyz
time
point
one
way
anova
duncan
multipl
rang
test
compar
pairwis
mean
differ
alpha
error
set
indic
signific
differ
p
group
author
declar
conflict
interest
respect
content
manuscript
